SEK165.60
0.24% today
Stockholm, Aug 12, 02:32 pm CET
ISIN
SE0000683484
Symbol
CEVI

CellaVision Stock price

SEK165.20
-17.80 9.73% 1M
-31.80 16.14% 6M
-52.30 24.05% YTD
-93.30 36.09% 1Y
-192.30 53.79% 3Y
-132.40 44.49% 5Y
+119.30 259.91% 10Y
+149.60 958.97% 20Y
Stockholm, Closing price Mon, Aug 11 2025
-0.40 0.24%
ISIN
SE0000683484
Symbol
CEVI

Key metrics

Basic
Market capitalization
SEK3.9b
Enterprise Value
SEK3.8b
Net debt
positive
Cash
SEK182.3m
Shares outstanding
-
Valuation (TTM | estimate)
P/E
26.1 | 22.7
P/S
5.3 | 5.0
EV/Sales
5.0 | 4.8
EV/FCF
31.9
P/B
4.7
Dividends
DPS
SEK2.50
Yield 1Y | 5Y
1.5% | 0.7%
Growth 1Y | 5Y
11.1% | -
Payout 1Y | 3Y
42.4% | 42.9%
Increased
1 Year
Financials (TTM | estimate)
Revenue
SEK751.5m | SEK793.6m
EBITDA
- | SEK266.7m
EBIT
SEK197.2m | SEK225.4m
Net Income
SEK151.2m | -
Free Cash Flow
SEK118.9m
Growth (TTM | estimate)
Revenue
3.5% | 9.7%
EBITDA
- | 32.5%
EBIT
7.3% | 26.9%
Net Income
4.2% | -
Free Cash Flow
-34.9%
Margin (TTM | estimate)
Gross
68.8%
EBITDA
- | 33.6%
EBIT
26.2%
Net
20.1% | -
Free Cash Flow
15.8%
Financial Health
Equity Ratio
80.5%
Return on Equity
17.3%
ROCE
-
ROIC
-
Debt/Equity
-
More
EPS
SEK6.3
FCF per Share
-
Short interest
-
Employees
219
Rev per Employee
SEK3.3m
Show more

Is CellaVision a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

CellaVision Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a CellaVision forecast:

8x Buy
89%
1x Hold
11%

Analyst Opinions

9 Analysts have issued a CellaVision forecast:

Buy
89%
Hold
11%

Financial data from CellaVision

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
751 751
3% 3%
100%
- Direct Costs 234 234
3% 3%
31%
517 517
7% 7%
69%
- Selling and Administrative Expenses 227 227
4% 4%
30%
- Research and Development Expense 94 94
12% 12%
12%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 197 197
7% 7%
26%
Net Profit 151 151
4% 4%
20%

In millions SEK.

Don't miss a Thing! We will send you all news about CellaVision directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

CellaVision AB engages in the provision of digital microscopy solutions for hematology laboratories. The firm's products include Analyzers, Instruments, DIFF-Line™ by CellaVision, Reagents, and Software and applications. It operates through the following geographical segments: Americas, APAC, and EMEA. The company was founded by Lars Christer Fedrik Fåhraeus on November 16, 1994 and is headquartered in Lund, Sweden.

Head office Sweden
CEO Simon Ostergaard
Employees 219
Founded 1994
Website www.cellavision.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today